Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases.
Fusobacterium necrophorum
Lemierre syndrome
anticoagulation
pulmonary embolism
septic embolism
venous thromboembolism
Journal
Journal of internal medicine
ISSN: 1365-2796
Titre abrégé: J Intern Med
Pays: England
ID NLM: 8904841
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
01
02
2020
revised:
17
04
2020
accepted:
20
04
2020
pubmed:
24
5
2020
medline:
4
9
2021
entrez:
24
5
2020
Statut:
ppublish
Résumé
Lemierre syndrome is characterized by head/neck vein thrombosis and septic embolism usually complicating an acute oropharyngeal bacterial infection in adolescents and young adults. We described the course of Lemierre syndrome in the contemporary era. In our individual-level analysis of 712 patients (2000-2017), we included cases described as Lemierre syndrome if these criteria were met: (i) primary site of bacterial infection in the head/neck; (ii) objectively confirmed local thrombotic complications or septic embolism. The study outcomes were new or recurrent venous thromboembolism or peripheral septic lesions, major bleeding, all-cause death and clinical sequelae. The median age was 21 (Q1-Q3: 17-33) years, and 295 (41%) were female. At diagnosis, acute thrombosis of head/neck veins was detected in 597 (84%) patients, septic embolism in 582 (82%) and both in 468 (80%). After diagnosis and during in-hospital follow-up, new venous thromboembolism occurred in 34 (5.2%, 95% CI 3.8-7.2%) patients, new peripheral septic lesions became evident in 76 (11.7%; 9.4-14.3%). The rate of either was lower in patients who received anticoagulation (OR: 0.59; 0.36-0.94), higher in those with initial intracranial involvement (OR: 2.35; 1.45-3.80). Major bleeding occurred in 19 patients (2.9%; 1.9-4.5%), and 26 died (4.0%; 2.7-5.8%). Clinical sequelae were reported in 65 (10.4%, 8.2-13.0%) individuals, often consisting of cranial nerve palsy (n = 24) and orthopaedic limitations (n = 19). Patients with Lemierre syndrome were characterized by a substantial risk of new thromboembolic complications and death. This risk was higher in the presence of initial intracranial involvement. One-tenth of survivors suffered major clinical sequelae.
Sections du résumé
BACKGROUND
Lemierre syndrome is characterized by head/neck vein thrombosis and septic embolism usually complicating an acute oropharyngeal bacterial infection in adolescents and young adults. We described the course of Lemierre syndrome in the contemporary era.
METHODS
In our individual-level analysis of 712 patients (2000-2017), we included cases described as Lemierre syndrome if these criteria were met: (i) primary site of bacterial infection in the head/neck; (ii) objectively confirmed local thrombotic complications or septic embolism. The study outcomes were new or recurrent venous thromboembolism or peripheral septic lesions, major bleeding, all-cause death and clinical sequelae.
RESULTS
The median age was 21 (Q1-Q3: 17-33) years, and 295 (41%) were female. At diagnosis, acute thrombosis of head/neck veins was detected in 597 (84%) patients, septic embolism in 582 (82%) and both in 468 (80%). After diagnosis and during in-hospital follow-up, new venous thromboembolism occurred in 34 (5.2%, 95% CI 3.8-7.2%) patients, new peripheral septic lesions became evident in 76 (11.7%; 9.4-14.3%). The rate of either was lower in patients who received anticoagulation (OR: 0.59; 0.36-0.94), higher in those with initial intracranial involvement (OR: 2.35; 1.45-3.80). Major bleeding occurred in 19 patients (2.9%; 1.9-4.5%), and 26 died (4.0%; 2.7-5.8%). Clinical sequelae were reported in 65 (10.4%, 8.2-13.0%) individuals, often consisting of cranial nerve palsy (n = 24) and orthopaedic limitations (n = 19).
CONCLUSIONS
Patients with Lemierre syndrome were characterized by a substantial risk of new thromboembolic complications and death. This risk was higher in the presence of initial intracranial involvement. One-tenth of survivors suffered major clinical sequelae.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
325-339Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
Références
Sacco C, Zane F, Granziera S et al. Lemierre syndrome: clinical update and protocol for a systematic review and individual patient data meta-analysis. Hamostaseologie2021; 39: 76-86.
Batty A, Wren MW. Prevalence of Fusobacterium necrophorum and other upper respiratory tract pathogens isolated from throat swabs. Br J Biomed Sci 2005; 62: 66-70.
Centor RM, Atkinson TP, Ratliff AE et al. The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med 2015; 162: 241-7.
Klug TE, Henriksen JJ, Fuursted K, Ovesen T. Significant pathogens in peritonsillar abscesses. European J Clin Microbiol Infect Dis 2011; 30: 619-27.
Atkinson TP, Centor RM, Xiao L et al. Analysis of the tonsillar microbiome in young adults with sore throat reveals a high relative abundance of Fusobacterium necrophorum with low diversity. PLoS One 2018; 13: e0189423.
Schuetz AN. Antimicrobial resistance and susceptibility testing of anaerobic bacteria. Clin Infect Dis 2014; 59: 698-705.
Kumar A, Menon S, Nagaraja TG, Narayanan S. Identification of an outer membrane protein of Fusobacterium necrophorum subsp. necrophorum that binds with high affinity to bovine endothelial cells. Vet Microbiol 2015; 176: 196-201.
Fardini Y, Wang X, Temoin S et al. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol 2011; 82: 1468-80.
Wang Q, Zhao L, Xu C, Zhou J, Wu Y. Fusobacterium nucleatum stimulates monocyte adhesion to and transmigration through endothelial cells. Arch Oral Biol 2019; 100: 86-92.
Friberg N, Carlson P, Kentala E et al. Factor H binding as a complement evasion mechanism for an anaerobic pathogen, Fusobacterium necrophorum. J Immunol 2008; 181: 8624-32.
Holm K, Collin M, Hagelskjaer-Kristensen L, Jensen A, Rasmussen M. Three variants of the leukotoxin gene in human isolates of Fusobacterium necrophorum subspecies funduliforme. Anaerobe 2017; 45: 129-32.
Forrester LJ, Campbell BJ, Berg JN, Barrett JT. Aggregation of platelets by Fusobacterium necrophorum. J Clin Microbiol 1985; 22: 245-9.
Kanoe M, Yamanaka M, Inoue M. Effects of Fusobacterium necrophorum on the mesenteric microcirculation of guinea pigs. Med Microbiol Immunol 1989; 178: 99-104.
Alberio L, Lammle B. Images in clinical medicine. Capnocytophaga canimorsus sepsis. N Engl J Med 1998; 339: 1827.
Lemierre A. On certain septicaemias due to anaerobic organisms. Lancet 1936; 1: 701-3.
Fränkel E. Title unavailable. Virch Arch 1925; 254: 639.
Stewart LA, Clarke M, Rovers M et al. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD Statement. JAMA 2015; 313: 1657-65.
Riordan T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome. Clin Microbiol Rev 2007; 20: 622-59.
Schulman S, Kearon C. Subcommittee on control of anticoagulation of the S, standardization Committee of the International Society on T, Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-4.
Holm K, Svensson PJ, Rasmussen M. Invasive Fusobacterium necrophorum infections and Lemierre's syndrome: the role of thrombophilia and EBV. Eur J Clin Microbiol Infect Dis 2015; 34: 2199-207.
Schubert AD, Hotz MA, Caversaccio MD, Arnold A. Septic thrombosis of the internal jugular vein: Lemierre's syndrome revisited. Laryngoscope 2015; 125: 863-8.
Creemers-Schild D. Fusobacterium necrophorum, an emerging pathogen of otogenic and paranasal infections? New Microb New Infect 2014; 2(3): 52-57.
Cupit-Link MC, Nageswara Rao A, Warad DM, Rodriguez V. Lemierre syndrome: a retrospective study of the role of anticoagulation and thrombosis outcomes. Acta Haematol 2017; 137: 59-65.
Lichosik LE. Syndrome de lemierre: propos de cinq cas du chu de nancy et revue de la litterature. 2010.
Pulcini C, Vandenbos F, Roth S et al. Syndrome de Lemierre: à propos de 6 cas. La Revue de Médecine Interne 2003; 24: 17-23.
Righini CA, Karkas A, Tourniaire R et al. Lemierre syndrome: study of 11 cases and literature review. Head Neck 2014; 36: 1044-51.
Trachsel L, Cherpillod J, Maestre LA, Gudinchet F. [Imaging of Lemierre in children and young adults]. Praxis 2013; 102: 1519-27.
Thuny F, Di Salvo G, Belliard O et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005; 112: 69-75.
Hubert S, Thuny F, Resseguier N et al. Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol 2013; 62: 1384-92.
Bondy P, Grant T. Lemierre's syndrome: what are the roles for anticoagulation and long-term antibiotic therapy? Ann Otol Rhinol Laryngol 2008; 117: 679-83.
Vanassche T, Peetermans WE, Herregods MC, Herijgers P, Verhamme P. Anti-thrombotic therapy in infective endocarditis. Expert Rev Cardiovasc Ther 2011; 9: 1203-19.
Monagle P, Lensing AWA, Thelen K et al. Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies. Lancet Haematol 2019; 6: e500-e9.
Pelland-Marcotte MC, Tucker C, Klaassen A et al. Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study. Lancet Haematol 2019; 6: e144-e53.
Syed MI, Baring D, Addidle M, Murray C, Adams C. Lemierre syndrome: two cases and a review. Laryngoscope 2007; 117: 1605-10.
Hagelskjaer Kristensen L, Prag J. Lemierre's syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey. Europ J Clin Microbiol Infect Dis 2008; 27: 779-89.
Barco S, Mahmoudpour SH, Valerio L et al. Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database. Lancet Res Med 2020; 8(3): 277-287.
Klok FA, Barco S. Follow-up after acute pulmonary embolism. Hamostaseologie 2018; 38: 22-32.
Righy C, Rosa RG, da Silva RTA et al. Prevalence of post-traumatic stress disorder symptoms in adult critical care survivors: a systematic review and meta-analysis. Crit Care 2019; 23: 213.
Jones C, Griffiths RD. Mental and physical disability after sepsis. Minerva Anestesiol 2013; 79: 1306-12.
Lai C. Lemierre's syndrome. New Engl J Med 2004; 350: e14.
Olson KR. Case 36-2014: A woman with fever, pharyngitis, and double vision. N Engl J Med 2015; 372: 579-81.
Tsai YJ. A Lemierre syndrome variant caused by Klebsiella pneumoniae. J Formos Med Assoc 2012; 111: 403-5.
Puymirat E, Biais M, Camou F, Lefevre J, Guisset O, Gabinski C. A Lemierre syndrome variant caused by Staphylococcus aureus. Am J Emerg Med 2008; 26: 380 e5-7.
Bouziri A, Douira W, Khaldi A et al. Neurological variant of Lemierre's Syndrome with purulent meningitis: a case report and literature review. Fetal Pediatr Pathol 2013; 31: 1-6.
Nygren D, Holm K. Invasive infections with Fusobacterium necrophorum including Lemierre's syndrome: an 8-year Swedish nationwide retrospective study. Clinical microbiology and infection : the official publication of the. Europ Soc Clin Microbiol Infect Dis 2019. [Epub ahead of print]. https://doi.org/10.1016/j.cmi.2019.12.002.